V-CO Investors LLC 13D and 13G filings for Vivos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-06-16 7:57 pm Purchase |
2025-06-09 | 13D | Vivos Therapeutics, Inc. VVOS |
V-CO Investors LLC | 1,342,498 19.900% |
828,000![]() (+160.93%) |
Filing |
2024-12-20 3:17 pm Purchase |
2024-12-17 | 13G | Vivos Therapeutics, Inc. VVOS |
V-CO Investors LLC | 514,498 9.900% |
514,498![]() (New Position) |
Filing |